Fresh versus frozen: initial transfer or cumulative cycle results: how do we interpret results and design studies?

Fertility and Sterility

Volumn 106, Issue 2, 2016, Pages 251-256

  Cedars, Marcelle I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Day 5 embryo transfer; delayed embryo transfer; freeze all; IVF; PGS

Indexed keywords

BIRTH RATE; BLASTOCYST; CLINICAL STUDY; CRYOPRESERVATION; EMBRYO CULTURE; EMBRYO TRANSFER; HUMAN; IN VITRO STUDY; INFERTILITY THERAPY; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW; SINGLE EMBRYO TRANSFER; STUDY DESIGN; ADVERSE EFFECTS; EVIDENCE BASED MEDICINE; FEMALE; FERTILITY; GENETIC SCREENING; IN VITRO FERTILIZATION; INFERTILITY; LIVE BIRTH; METHODOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY RATE; PREIMPLANTATION GENETIC DIAGNOSIS; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

CRYOPRESERVATION; EMBRYO TRANSFER; EVIDENCE-BASED MEDICINE; FEMALE; FERTILITY; FERTILIZATION IN VITRO; GENETIC TESTING; HUMANS; INFERTILITY; LIVE BIRTH; PREGNANCY; PREGNANCY RATE; PREIMPLANTATION DIAGNOSIS; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84979665853     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2016.06.001     Document Type: Review

References (52)

1. 1 Doody, K.J., Cryopreservation and delayed embryo transfer-assisted reproductive technology registry and reporting implications. Fertil Steril 102 (2014), 27–31.
2. 2 Wada, I., Matson, P.L., Troup, S.A., Morroll, D.R., Hunt, L., Lieberman, B.A., Does elective cryopreservation of all embryos from women at risk of ovarian hyperstimulation syndrome reduce the incidence of the condition?. Br J Obstet Gynaecol 100 (1993), 265–269.
3. 3 Pelkonen, S., Koivunen, R., Gissler, M., Nuojua-Huttunen, S., Suikkari, A.M., Hyden-Granskog, C., et al. Perinatal outcome of children born after frozen and fresh embryo transfer: the Finnish cohort study 1995–2006. Hum Reprod 25 (2010), 914–923.
4. 4 D'Angelo, A., Amso, N., Embryo freezing for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev, 2007, CD002806.
5. 5 Shapiro, B.S., Daneshmand, S.T., Garner, F.C., Aguirre, M., Hudson, C., Freeze-all can be a superior therapy to another fresh cycle in patients with prior fresh blastocyst implantation failure. Reprod Biomed Online 29 (2014), 286–290.
6. 6 Wong, K.M., Mastenbroek, S., Repping, S., Cryopreservation of human embryos and its contribution to in vitro fertilization success rates. Fertil Steril 102 (2014), 19–26.
7. 7 Weinerman, R., Mainigi, M., Why we should transfer frozen instead of fresh embryos: the translational rationale. Fertil Steril 102 (2014), 10–18.
8. 8 Wennerholm, U.B., Henningsen, A.K., Romundstad, L.B., Bergh, C., Pinborg, A., Skjaerven, R., et al. Perinatal outcomes of children born after frozen-thawed embryo transfer: a Nordic cohort study from the CoNARTaS group. Hum Reprod 28 (2013), 2545–2553.
9. 9 Williams, R.S., Doody, K.J., Schattman, G.L., Adashi, E.Y., Public reporting of assisted reproductive technology outcomes: past, present, and future. Am J Obstet Gynecol 212 (2015), 157–162.
10. 10 Glujovsky, D., Blake, D., Farquhar, C., Bardach, A., Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev, 2012, CD002118.
11. 11 Shapiro, B.S., Daneshmand, S.T., Garner, F.C., Aguirre, M., Hudson, C., Thomas, S., Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil Steril 96 (2011), 344–348.
12. 12 Shapiro, B.S., Daneshmand, S.T., Garner, F.C., Aguirre, M., Hudson, C., Thomas, S., Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfers in high responders. Fertil Steril 96 (2011), 516–518.
13. 13 Scott, R.T. Jr., Upham, K.M., Forman, E.J., Hong, K.H., Scott, K.L., Taylor, D., et al. Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertil Steril 100 (2013), 697–703.
14. 14 Yang, Z., Salem, S.A., Liu, X., Kuang, Y., Salem, R.D., Liu, J., Selection of euploid blastocysts for cryopreservation with array comparative genomic hybridization (aCGH) results in increased implantation rates in subsequent frozen and thawed embryo transfer cycles. Mol Cytogenet, 6, 2013, 32.
15. 15 Forman, E.J., Upham, K.M., Cheng, M., Zhao, T., Hong, K.H., Treff, N.R., et al. Comprehensive chromosome screening alters traditional morphology-based embryo selection: a prospective study of 100 consecutive cycles of planned fresh euploid blastocyst transfer. Fertil Steril 100 (2013), 718–724.
16. 16 Barnhart, K., Osheroff, J., Follicle stimulating hormone as a predictor of fertility. Curr Opin Obstet Gynecol 10 (1998), 227–232.
17. 17 Franasiak, J.M., Forman, E.J., Hong, K.H., Werner, M.D., Upham, K.M., Treff, N.R., et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril 101 (2014), 656–663.e1.
18. 18 Farhi, J., Ben-Haroush, A., Andrawus, N., Pinkas, H., Sapir, O., Fisch, B., et al. High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation. Reprod Biomed Online 21 (2010), 331–337.
19. 19 Imudia, A.N., Awonuga, A.O., Doyle, J.O., Kaimal, A.J., Wright, D.L., Toth, T.L., et al. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization. Fertil Steril 97 (2012), 1374–1379.
20. 20 Imudia, A.N., Awonuga, A.O., Kaimal, A.J., Wright, D.L., Styer, A.K., Toth, T.L., Elective cryopreservation of all embryos with subsequent cryothaw embryo transfer in patients at risk for ovarian hyperstimulation syndrome reduces the risk of adverse obstetric outcomes: a preliminary study. Fertil Steril 99 (2013), 168–173.
21. 21 Imudia, A.N., Goldman, R.H., Awonuga, A.O., Wright, D.L., Styer, A.K., Toth, T.L., The impact of supraphysiologic serum estradiol levels on peri-implantation embryo development and early pregnancy outcome following in vitro fertilization cycles. J Assist Reprod Genet 31 (2014), 65–71.
22. 22 Joo, B.S., Park, S.H., An, B.M., Kim, K.S., Moon, S.E., Moon, H.S., Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner. Fertil Steril 93 (2010), 442–446.
23. 23 Kyrou, D., Popovic-Todorovic, B., Fatemi, H.M., Bourgain, C., Haentjens, P., Van Landuyt, L., et al. Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist?. Hum Reprod 24 (2009), 2902–2909.
24. 24 Fauser, B.C., de Jong, D., Olivennes, F., Wramsby, H., Tay, C., Itskovitz-Eldor, J., et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab 87 (2002), 709–715.
25. 25 Humaidan, P., Bredkjaer, H.E., Bungum, L., Bungum, M., Grondahl, M.L., Westergaard, L., et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 20 (2005), 1213–1220.
26. 26 Kolibianakis, E.M., Schultze-Mosgau, A., Schroer, A., van Steirteghem, A., Devroey, P., Diedrich, K., et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod 20 (2005), 2887–2892.
27. 27 Humaidan, P., Van Vaerenbergh, I., Bourgain, C., Alsbjerg, B., Blockeel, C., Schuit, F., et al. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles. Hum Reprod 27 (2012), 3259–3272.
28. 28 Yding Andersen, C., Vilbour Andersen, K., Improving the luteal phase after ovarian stimulation: reviewing new options. Reprod Biomed Online 28 (2014), 552–559.
29. 29 Fatemi, H.M., Popovic-Todorovic, B., Implantation in assisted reproduction: a look at endometrial receptivity. Reprod Biomed Online 27 (2013), 530–538.
30. 30 Meyer, W.R., Novotny, D.B., Fritz, M.A., Beyler, S.A., Wolf, L.J., Lessey, B.A., Effect of exogenous gonadotropins on endometrial maturation in oocyte donors. Fertil Steril 71 (1999), 109–114.
31. 31 Liu, Y., Lee, K.F., Ng, E.H., Yeung, W.S., Ho, P.C., Gene expression profiling of human peri-implantation endometria between natural and stimulated cycles. Fertil Steril 90 (2008), 2152–2164.
32. 32 Santos, M.A., Kuijk, E.W., Macklon, N.S., The impact of ovarian stimulation for IVF on the developing embryo. Reproduction 139 (2010), 23–34.
33. 33 Mainigi, M.A., Olalere, D., Burd, I., Sapienza, C., Bartolomei, M., Coutifaris, C., Peri-implantation hormonal milieu: elucidating mechanisms of abnormal placentation and fetal growth. Biol Reprod, 90, 2014, 26.
34. 34 Kalra, S.K., Ratcliffe, S.J., Coutifaris, C., Molinaro, T., Barnhart, K.T., Ovarian stimulation and low birth weight in newborns conceived through in vitro fertilization. Obstet Gynecol 118 (2011), 863–871.
35. 35 Henningsen, A.K., Pinborg, A., Lidegaard, O., Vestergaard, C., Forman, J.L., Andersen, A.N., Perinatal outcome of singleton siblings born after assisted reproductive technology and spontaneous conception: Danish national sibling-cohort study. Fertil Steril 95 (2011), 959–963.
36. 36 Pinborg, A., Loft, A., Aaris Henningsen, A.K., Rasmussen, S., Andersen, A.N., Infant outcome of 957 singletons born after frozen embryo replacement: the Danish National Cohort Study 1995–2006. Fertil Steril 94 (2010), 1320–1327.
37. 37 Stehlik, E., Stehlik, J., Katayama, K.P., Kuwayama, M., Jambor, V., Brohammer, R., et al. Vitrification demonstrates significant improvement versus slow freezing of human blastocysts. Reprod Biomed Online 11 (2005), 53–57.
38. 38 Balaban, B., Urman, B., Ata, B., Isiklar, A., Larman, M.G., Hamilton, R., et al. A randomized controlled study of human day 3 embryo cryopreservation by slow freezing or vitrification: vitrification is associated with higher survival, metabolism and blastocyst formation. Hum Reprod 23 (2008), 1976–1982.
39. 39 Keskintepe, L., Sher, G., Machnicka, A., Tortoriello, D., Bayrak, A., Fisch, J., et al. Vitrification of human embryos subjected to blastomere biopsy for pre-implantation genetic screening produces higher survival and pregnancy rates than slow freezing. J Assist Reprod Genet 26 (2009), 629–635.
40. 40 Son, W.Y., Chung, J.T., Gidoni, Y., Holzer, H., Levin, D., Chian, R.C., et al. Comparison of survival rate of cleavage stage embryos produced from in vitro maturation cycles after slow freezing and after vitrification. Fertil Steril 92 (2009), 956–958.
41. 41 Shin, M.R., Choi, H.W., Kim, M.K., Lee, S.H., Lee, H.S., Lim, C.K., In vitro development and gene expression of frozen-thawed 8-cell stage mouse embryos following slow freezing or vitrification. Clin Exp Reprod Med 38 (2011), 203–209.
42. 42 Saenz-de-Juano, M.D., Marco-Jimenez, F., Viudes-de-Castro, M.P., Lavara, R., Vicente, J.S., Direct comparison of the effects of slow freezing and vitrification on late blastocyst gene expression, development, implantation and offspring of rabbit morulae. Reprod Domest Anim 49 (2014), 505–511.
43. 43 Staessen, C., Platteau, P., Van Assche, E., Michiels, A., Tournaye, H., Camus, M., et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 19 (2004), 2849–2858.
44. 44 Blockeel, C., Schutyser, V., De Vos, A., Verpoest, W., De Vos, M., Staessen, C., et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reprod Biomed Online 17 (2008), 848–854.
45. 45 Staessen, C., Verpoest, W., Donoso, P., Haentjens, P., Van der Elst, J., Liebaers, I., et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Hum Reprod 23 (2008), 2818–2825.
46. 46 Garrisi, J.G., Colls, P., Ferry, K.M., Zheng, X., Garrisi, M.G., Munne, S., Effect of infertility, maternal age, and number of previous miscarriages on the outcome of preimplantation genetic diagnosis for idiopathic recurrent pregnancy loss. Fertil Steril 92 (2009), 288–295.
47. 47 Schoolcraft, W.B., Katz-Jaffe, M.G., Stevens, J., Rawlins, M., Munne, S., Preimplantation aneuploidy testing for infertile patients of advanced maternal age: a randomized prospective trial. Fertil Steril 92 (2009), 157–162.
48. 48 Debrock, S., Melotte, C., Spiessens, C., Peeraer, K., Vanneste, E., Meeuwis, L., et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertil Steril 93 (2010), 364–373.
49. 49 Ajduk, A., Zernicka-Goetz, M., Advances in embryo selection methods. F1000 Biol Rep, 4, 2012, 11.
50. 50 Mantikou, E., Wong, K.M., Repping, S., Mastenbroek, S., Molecular origin of mitotic aneuploidies in preimplantation embryos. Biochim Biophys Acta 1822 (2012), 1921–1930.
51. 51 Scott, R.T. Jr., Upham, K.M., Forman, E.J., Zhao, T., Treff, N.R., Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil Steril 100 (2013), 624–630.
52. 52 Lee, E., Illingworth, P., Wilton, L., Chambers, G.M., The clinical effectiveness of preimplantation genetic diagnosis for aneuploidy in all 24 chromosomes (PGD-A): systematic review. Hum Reprod 30 (2015), 473–483.